儿童社区获得性肺炎短疗程与长疗程抗生素治疗的Meta分析
结果显示两组在临床治愈、治疗失败、复发、死亡、换药、住院及严重不良事件方面均无显著差异,证据确定性中至高。作者建议门诊口服治疗的患儿优先选择短疗程抗生素。
要点
- 短疗程与长疗程抗生素在临床治愈、治疗失败和复发上无重要差异。
- 短疗程不增加死亡、换药、住院或严重不良事件风险。
- 门诊口服抗生素治疗的CAP患儿应优先选择短疗程方案。
核心结论
- 抗生素疗程长短对患儿重要结局可能无重要影响,应优先使用短疗程。
主要发现
- 短疗程与长疗程在临床治愈(OR 1.01,95%CI 0.87-1.17;RD 0.1%;中等确定性)、治疗失败(RR 1.06,95%CI 0.93-1.21;RD 0.3%;中等确定性)和复发(RR 1.12,95%CI 0.92-1.35;RD 0.5%;中等确定性)上可能无实质差异。
- 短疗程不显著增加死亡(RD 0.0%,95%CI -0.2至0.1;高确定性),对换药(RR 1.03,95%CI 0.72-1.47;RD 0.2%;中等确定性)、住院(RD -0.2%,95%CI -0.9至0.5;中等确定性)和严重不良事件(RD 0.0%,95%CI -0.2至0.2;中等确定性)影响很小或无影响。
关键数值与推荐
- 短疗程定义为≤5天,长疗程定义未在摘要中具体说明。
临床怎么用
- 对门诊口服抗生素治疗的CAP患儿,医生应优先选择短疗程(≤5天)方案。
局限性
- 部分结局缺乏证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The optimal duration of antibiotic treatment of children with community-acquired pneumonia (CAP) remains unclear. OBJECTIVES: This study aimed to compare the efficacy and safety of shorter versus longer duration of antibiotic treatment of children with CAP. DATA SOURCES: We searched Medline, Embase, CENTRAL, and CINAHL. STUDY SELECTION: Randomized clinical trials comparing shorter (≤5 days) with longer duration antibiotic treatments in children with CAP. DATA EXTRACTION: Paired reviewers independently extracted data and we performed random-effects meta-analyses to summarize the evidence. RESULTS: Sixteen trials with 12 774 patients, treated as outpatients with oral antibiotics, proved eligible. There are probably no substantial differences between shorter-duration and longer-duration antibiotics in clinical cure (odds ratio 1.01, 95% confidence interval [CI] 0.87 to 1.17; risk difference [RD] 0.1%; moderate certainty), treatment failure (relative risk [RR] 1.06, 95% CI 0.93 to 1.21; RD 0.3%; moderate certainty), and relapse (RR 1.12, 95% CI 0.92 to 1.35; RD 0.5%; moderate certainty). Compared with longer-duration antibiotics, shorter-duration antibiotics do not appreciably increase mortality (RD 0.0%, 95% CI -0.2 to 0.1; high certainty), and probably have little or no impact on the need for change in antibiotics (RR 1.03, 95% CI 0.72 to 1.47; RD 0.2%; moderate certainty), need for hospitalization (RD -0.2%, 95% CI -0.9 to 0.5; moderate certainty), and severe adverse events (RD 0.0%, 95% CI -0.2 to 0.2; moderate certainty). LIMITATIONS: For some outcomes, evidence was lacking. CONCLUSIONS: Duration of antibiotic therapy likely makes no important difference in patient-important outcomes. Healthcare workers should prioritize the use of shorter-duration antibiotics for children with CAP treated as outpatients with oral antibiotics.
引用
- Gao Y, Liu M, Yang K, et al. Shorter Versus Longer-term Antibiotic Treatments for Community-Acquired Pneumonia in Children: A Meta-analysis. Pediatrics. 2023. PMID: 37226686. doi:10.1542/peds.2022-060097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。